WATCH LIVE Dec. 15 (EST) - EST (Eastern Standard Time, GMT-5)

9:30am - 10:00am30 mins

Scientific Briefing 1

Scientific Briefings

9:30am - 10:00am30 mins

Scientific Briefing 2

Scientific Briefings

LIVE Moderated Panel Discussions with Audience Q&A - To prepare for these discussions/Q&As, attendees should view the presentations from these sessions in the Watch On-Demand Sessions Tab in advance

10:15am - 11:00am45 mins

Sourcing Disease-specific Human Antibodies from Patient Repertoires

Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
Norman Michael Greenberg, Ph.D. - Chief Scientific Officer and SVP, Atreca Inc
Nina Luning Prak, M.D., Ph.D. - Professor of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School
Leslie Goo, Ph.D. - Assistant Professor Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center
Sarav Rajan, Ph.D. - Senior Scientist, AstraZeneca

10:15am - 11:00am45 mins

Transforming Therapeutic Targets

Greg Lazar, Ph.D. - Director and Senior Scientist, Antibody Engineering, Genentech
Oliver Hills, Ph.D. - VP Drug Discovery/Lead Optimization, Apogenix AG
Maria Jure-Kunkel, Ph.D. - Head of Late Stage Oncology Translational Medicine, Genmab
Michael Curran, Ph.D. - Associate Professor, Department of Immunology, The UT MD Anderson Cancer Center
Thomas Schürpf, Ph.D. - Associate Director, Discovery Biology, Scholar Rock
Denise Faustman, M.D., Ph.D. - Associate Professor of Medicine, Harvard Medical School

On Demand

Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A

11:15am - 12:00pm45 mins

Engineering Bispecific Antibodies as Therapeutics: Utilizing Intrinsic Heavy/Light Chain Pairing Preferences and Mitigating High Viscosity

Paul Carter, PhD - Genentech Fellow, Department of Antibody Engineering, Genentech, Inc.

LIVE Moderated Panel Discussions with Audience Q&A - To prepare for these discussions/Q&As, attendees should view the presentations from these sessions in the Watch On-Demand Sessions Tab in advance

12:15pm - 1:00pm45 mins

FcR and Antibody Effector Functions

Falk Nimmerjahn, PhD - Professor, University of Erlangen-Nuremberg
Galit Alter, Ph.D. - Professor of Medicine, Harvard Medical School and Group Leader, Ragon Institute of MGH, MIT and Harvard
Tanya Mayadas, Ph.D. - Professor of Pathology, Center for Excellence in V, Brigham and Women's Hospital
Stephen Beers, PhD - Professor of Immunology and Immunotherapy, Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton
Lynn MacDonald, Ph.D. - Vice President, Research, Regeneron
Björn Frendéus, Ph.D. - Chief Scientific Officer, BioInvent International AB
Anna Park, Ph.D. - Distinguished Scientist, Head of Protein Engineering, Sanofi

12:15pm - 1:00pm45 mins

Developments in ADC Technology

Matthew Levengood, Ph.D. - Principal Scientist, Protein Sciences, Seattle Genetics
Jack Sadowsky, PhD - Senior Scientist, Genentech
David Thurston - Professor Drug Discovery, Kings College London
Trevor Hallam, Ph.D. - Chief Scientific Officer, Sutro Biopharma
Christian Rohlff - Chief Executive Officer & Founder, Oxford BioTherapeutics

1:00pm - 2:00pm60 mins

FREE TIME: Visit the Solution Provider Showcase - Virtual Hubs, View Posters, On-Demand Sessions or Schedule 1:1 Meetings with other Attendees

2:00pm - 2:30pm30 mins

Scientific Briefing 1

Scientific Briefings

2:00pm - 2:30pm30 mins

Scientific Briefing 2

Scientific Briefings

2:30pm - 2:45pm15 mins

Scientific Briefing 1

View our 10-Minute Hot Topic Presentations

2:30pm - 2:45pm15 mins

Scientific Briefing 2

View our 10-Minute Hot Topic Presentations

2:45pm - 3:15pm30 mins

Scientific Briefing 1

Scientific Briefings

2:45pm - 3:15pm30 mins

Scientific Briefing 2

Scientific Briefings

LIVE Moderated Panel Discussion with Audience Q&A - To prepare for this discussion/Q&A, attendees should view the presentations from this session in the Watch On-Demand Sessions Tab in advance

3:30pm - 4:15pm45 mins

Inducible Activation of Antibodies to Enhance Therapeutic Index

Paul Carter, PhD - Genentech Fellow, Department of Antibody Engineering, Genentech, Inc.
Marcia Balvin, Ph.D. - Vice President Research Oncology, CytomX Therapeutics
William Boyle, Ph.D - Chief of Translation Medicine, BioAtla
Tim Clackson, Ph.D. - President & EVP R&D, Xilio Therapeutics
Volker Schellenberger, Ph.D. - CEO and President, Amunix
William Winston, Ph.D. - Vice President, Research, Werewolf Therapeutics
Julie Su - Senior Scientist, Bristol-Myers Squibb
Mika Kamata-Sakurai, Ph.D. - Senior Director, Translational Research Division, Chugai Pharmaceutical Co., Ltd.

4:15pm - 4:45pm30 mins

Meet the Poster Presenters Session (Even-Numbered Posters Only - #2, #4, #6, etc.): Talk Live with Poster Presenters Who Will Be Available to Discuss Their Virtual Posters During This Session

4:45pm - 4:50pm5 mins

Close of Day 2

WATCH LIVE Dec. 15 (EST) - EST (Eastern Standard Time, GMT-5)

WATCH LIVE Dec. 15 (EST) - EST (Eastern Standard Time, GMT-5)

Get the latest news.As it happens

Get the latest news.
As it happens